Browse studies, page 1162
Page 1162 of 1,203, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study) Therapeutic Advances in Infectious Disease, 2026
- Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial Respiratory medical research, 2020
- Effectiveness of Yinhua Pinggan granules in community-acquired pneumonia: a randomized, double-blind clinical trial Frontiers in Pharmacology, 2025
- Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial medRxiv, 2021
- Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study) Intensive Care Medicine, 2018
- Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial Probiotics and Antimicrobial Proteins, 2021
- A randomized, double-blind, placebo-controlled, multicenter clinical trial for efficacy and safety of traditional Chinese medicine combined with antibiotics in the treatment of bacterial pneumonia in children Medicine, 2020
- Efficacy and safety of Xiyanping injection in the treatment of COVID‐19: A multicenter, prospective, open‐label and randomized controlled trial Phytotherapy Research, 2021
- Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial Annals of Intensive Care, 2023
- Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A Post Hoc Analysis of a Randomized Controlled Trial Frontiers in Pharmacology, 2022
- Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial Journal of Clinical Medicine, 2022
- Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial Frontiers in Pharmacology, 2022
- Remote Ischemic Conditioning in the Prevention for Stroke-Associated Pneumonia: A Pilot Randomized Controlled Trial Frontiers in Neurology, 2022
- Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial Trials, 2021
- Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial) Scientific Reports, 2022
- Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial Frontiers in Nutrition, 2025
- Clinical Efficacy Protocol of Yinhuapinggan Granules: A Randomized, Double-Blind, Parallel, and Controlled Clinical Trial Program for the Intervention of Community-Acquired Drug-Resistant Bacterial Pneumonia as a Complementary Therapy Frontiers in Pharmacology, 2022
- Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19 Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2022
- Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study Frontiers in Medicine, 2024
- Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial Frontiers in Pharmacology, 2022
- Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID) Pneumonia, 2024
- Efficacy of continuous versus intermittent subglottic secretion drainage in preventing ventilator-associated pneumonia in patients requiring mechanical ventilation: A single-center randomized controlled trial OncoTarget, 2018
- Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial Clinical Infectious Diseases, 2024
- A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study Trials, 2024
- Efficacy of Adjunctive Zinc in Improving the Treatment Outcomes in Hospitalized Children with Pneumonia: A Randomized Controlled Trial Journal of Tropical Pediatrics, 2019
- Yinma Jiedu granules combined with antibacterial drugs for patients with community-acquired pneumonia: protocol for a multicenter, randomized, double-blind, placebo-parallel controlled clinical trial Frontiers in Medicine, 2025
- Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial Journal of Inflammation, 2020
- Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial Clinical Microbiology and Infection, 2023
- Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial The Lancet Regional Health - Europe, 2025
- A Prospective phase IIA Multicenter Double-Blinded Randomized Placebo-Controlled Clinical Trial Evaluating the Efficacy and Safety of Inhaled Tobramycin in Patients with Ventilator-Associated Pneumonia (iToVAP) Anaesthesia Critical Care & Pain Medicine, 2023
- A randomized, controlled, multicenter clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus moxifloxacin in adult patients with community-acquired pneumonia Current Medical Research and Opinion, 2021
- Efficacy of an Herbal Preparation (Atomy’s HemoHIM®) against Ventilator-associated Pneumonia: A Randomized Controlled Clinical Trial Journal of Research in Pharmacy Practice, 2023
- Comparison of Efficacy and Safety Profiles Between Omadacycline and Moxifloxacin in Elderly Patients with Community-Acquired Pneumonia: A Randomized, Controlled Trial Clinical pharmacology in drug development, 2025
- Efficacy and safety of anemoside B4 in canine pneumonia treatment: a prospective, randomized controlled trial Frontiers in Veterinary Science, 2025
- Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial Critical care (London, England), 2011
- The Impact of an Antimicrobial Utilization Program on Antimicrobial Use at a Large Teaching Hospital: A Randomized Controlled Trial Infection control and hospital epidemiology, 2009
- Exposure to ceftobiprole is associated with microbiological eradication and clinical cure in patients with nosocomial pneumonia Antimicrobial agents and chemotherapy, 2014
- Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial Lancet (London, England), 2020
- Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019
- Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers Drug design, development and therapy, 2016
- Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial Trials, 2016
- High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: A randomized clinical trial PloS one, 2018
- Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial PloS one, 2017
- Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial International journal of chronic obstructive pulmonary disease, 2015
- Pharmacokinetics and Safety of Intravenous Murepavadin Infusion in Healthy Adult Subjects Administered Single and Multiple Ascending Doses Antimicrobial agents and chemotherapy, 2018
- Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021
- A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018
- Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial Chinese medical journal, 2017
- A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection BMC infectious diseases, 2018
- Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6 PloS one, 2020
- Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019
- In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial Antimicrobial agents and chemotherapy, 2020
- A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19) PloS one, 2020
- In Vitro Activity of Ceftazidime-Avibactam against Isolates from Patients in a Phase 3 Clinical Trial for Treatment of Complicated Intra-abdominal Infections Antimicrobial agents and chemotherapy, 2018
- Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia The Pediatric infectious disease journal, 2022
- A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy subjects Annals of medicine, 2021
- Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019
- Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial Critical care (London, England), 2020
- Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial Journal of hematology & oncology, 2021
- Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study International immunopharmacology, 2021
- Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management Blood cancer journal, 2020
- Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial Blood advances, 2022
- Vitamin D supplementation among Bangladeshi children under-five years of age hospitalised for severe pneumonia: A randomised placebo controlled trial PloS one, 2021
- Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units BMJ open, 2021
- Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia Medicine, 2020
- Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial BMC infectious diseases, 2021
- Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023
- The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022
- Clinical efficacy of ulinastatin in the treatment of unliquefied pyogenic liver abscess complicated by septic shock: A randomized controlled trial Immunity, inflammation and disease, 2023
- Virgin coconut oil (VCO) supplementation relieves symptoms and inflammation among COVID-19 positive adults: a single-blind randomized trial Journal of nutritional science, 2024
- Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection The Pediatric infectious disease journal, 2023
- Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022
- Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement Science translational medicine, 2023
- A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia The Journal of antimicrobial chemotherapy, 2024
- Effectiveness of the modified TaWai mobile application for reporting adverse drug reaction in Lao PDR: a cluster randomized controlled trial Scientific reports, 2024
- Efficacy of empirical Ciprofloxacin or Cefixime plus Metronidazole therapy for the treatment of liver abscess: a randomized control clinical trial Scientific reports, 2024
- Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial Nature communications, 2024
- Clinical study on the treatment of Qingfei Paidu Granules combined with nondrug therapy for asymptomatic patients with novel coronavirus Medicine, 2024
- Etiology and efficacy of anti-microbial treatment for community-acquired pneumonia in adults requiring hospital admission in Ukraine Acta bio-medica : Atenei Parmensis, 2022
- Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II study Haematologica, 2024
- Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial Antimicrobial resistance and infection control, 2025
- DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis BMC infectious diseases, 2025
- Management of Ventilator-Associated Pneumonia Caused by Pseudomonas and Acinetobacter Organisms in a Pediatric Center: A Randomized Controlled Study Medicina (Kaunas, Lithuania), 2024
- An ex-vivo pharmacodynamic study comparing bactericidal activity of amoxicillin/sulbactam, azithromycin, doxycycline and levofloxacin against Streptococcus pneumoniae Journal of chemotherapy (Florence, Italy), 2004
- An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients Rhinology, 2004
- Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate International journal of antimicrobial agents, 2002
- Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2005
- A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia Clinical therapeutics, 2005
- Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study The Journal of antimicrobial chemotherapy, 1999
- A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections Chest, 1999
- Predictors of symptom resolution in patients with community-acquired pneumonia Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000
- High-dose levofloxacin in community-acquired pneumonia: a randomized, open-label study Clinical drug investigation, 2012
- Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study BJOG : an international journal of obstetrics and gynaecology, 2010
- Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease International journal of chronic obstructive pulmonary disease, 2013
- Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial Trials, 2015
- Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy Pulmonary pharmacology & therapeutics, 2017
- Low-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia: a systematic review and meta-analysis Frontiers in Pharmacology, 2024
- Intermittent Versus Daily Trimethoprim/Sulfamethoxazole Regimens for Pneumocystis Pneumonia Prophylaxis: A Systematic Review and Meta-analysis Open Forum Infectious Diseases, 2024
- Carbapenem vs. non-carbapenem antibiotics for ventilator-associated pneumonia: A systematic review with meta-analysis Respiratory Investigation, 2024
- Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis Canadian Medical Association Journal, 2020
